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Molecular oxygen, with its high oxidation potential, har-
bors considerable energy that powers aerobic life on earth. 
The driving force for biological oxygenation derives ulti-
mately from the large, 80 kcal/mol favorable enthalpic 
change inherent to the four-electron reduction of oxygen 
to water. Paradoxically, however, O2 in its triplet ground 
state is a kinetically slow oxidant due to its thermody-
namic stability. The one-electron reduction of 3O2 to the 
superoxide ion is endergonic by 7.8 kcal/mol and the bond 
dissociation energy of H–OO· is only 47 kcal/mol [1–4]. 
Further, the triplet ground state of O2 imposes spin-flip bar-
riers to two-electron processes involving closed shell reac-
tion partners such as typical organic compounds [5, 6]. To 
exploit the oxidative power of O2, nature has developed a 
diverse range of enzyme cofactors to activate triplet O2. A 
good example is the family of flavin-dependent oxidases 
and oxygenases, in which a reduced flavin reacts read-
ily with triplet O2 to form hydroperoxyflavin intermediate 
despite the required triplet-to-singlet spin inversion [7–9]. 
The majority of O2-activation enzymes utilize cofactors 
Abstract Since our initial report in 1976, the oxygen 
rebound mechanism has become the consensus mechanistic 
feature for an expanding variety of enzymatic C–H func-
tionalization reactions and small molecule biomimetic cata-
lysts. For both the biotransformations and models, an initial 
hydrogen atom abstraction from the substrate (R–H) by 
high-valent iron-oxo species (Fen=O) generates a substrate 
radical and a reduced iron hydroxide, [Fen−1–OH ·R]. This 
caged radical pair then evolves on a complicated energy 
landscape through a number of reaction pathways, such 
as oxygen rebound to form R–OH, rebound to a non-oxy-
gen atom affording R–X, electron transfer of the incipient 
radical to yield a carbocation, R+, desaturation to form ole-
fins, and radical cage escape. These various flavors of the 
rebound process, often in competition with each other, give 
rise to the wide range of C–H functionalization reactions 
performed by iron-containing oxygenases. In this review, 
we first recount the history of radical rebound mechanisms, 
their general features, and key intermediates involved. We 
will discuss in detail the factors that affect the behavior of 
the initial caged radical pair and the lifetimes of the incipi-
ent substrate radicals. Several representative examples of 
enzymatic C–H transformations are selected to illustrate 
how the behaviors of the radical pair [Fen−1–OH ·R] deter-
mine the eventual reaction outcome. Finally, we discuss the 
powerful potential of “radical rebound” processes as a gen-
eral paradigm for developing novel C–H functionalization 
reactions with synthetic, biomimetic catalysts. We envision 
that new chemistry will continue to arise by bridging enzy-
matic “radical rebound” with synthetic organic chemistry.
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containing transition metals, such as iron, copper, and 
occasionally manganese. These d-block metals, with their 
multiple spin states and oxidation states, are employed for 
numerous oxidative transformations in biology such as ali-
phatic C–H hydroxylations and halogenations [1, 2, 10–
16]. Perhaps not surprisingly, these metal-catalyzed oxida-
tive enzymatic transformations share common mechanistic 
features in which oxygen is sequentially reduced to super-
oxo, peroxo, hydroxo, and high-valent metal-oxo interme-
diates, which are then exploited to activate substrates via 
hydrogen atom abstraction. The resulting substrate radi-
cal can then be transformed in a variety of ways (Fig. 1). 
Mechanistic examinations of these enzymatic transforma-
tions over the past four decades have revealed not only how 
these enzymes work. They have provided the impetus for 
the development of the field of bioinorganic chemistry, 
particularly high-valent metal coordination chemistry, and 
opened new frontiers in synthetic chemistry, led by novel, 
biomimetic catalytic systems for direct aliphatic C–H func-
tionalizations [17–21].
Mechanisms of C–H activation by cytochrome 
P450s and other iron‑containing oxygenases
The heme-thiolate-containing monooxygenases, 
cytochrome P450, have assumed a uniquely important posi-
tion in the hierarchy of the field and served as prototypical 
example to our understanding of the iron-containing oxyge-
nases [22–25]. P450 enzymes (now termed CYP) catalyze 
highly selective C–H hydroxylations, as well as epoxida-
tions, desaturations, dealkylations, and C–C bond cleavage 
reactions in an extremely wide range of compounds. Typi-
cal substrates include xenobiotics such as pharmaceuticals 
and agrochemicals and precursors for the biosynthesis of 
steroids, terpenoids, alkaloids, antibiotics, pigments, anti-
oxidants, etc. Bacterial P450s have been genetically engi-
neered for large-scale bio-transformations [26, 27].
The consensus mechanism of P450-catalyzed hydroxy-
lation that has come to be known as the oxygen rebound 
mechanism is shown in Fig. 2, as proposed by us in 
1970s [28–30]. The key feature of this mechanism is the 
involvement of an oxoiron(IV) porphyrin cation radi-
cal intermediate (compound I) that abstracts a hydrogen 
atom from the substrate to form [FeIV–OH ·R] and the 
subsequent rebound of the incipient substrate radical to a 
hydroxoiron(IV) intermediate (compound II) [31, 32].
The basic concept of the oxygen rebound mechanism 
stemmed from our early studies of Fenton’s reagent—a 
mixture of hydrogen peroxide and ferrous salts that can 
hydroxylate alkanes [33, 34]. There were extensive debates 
in the field at that time regarding whether the hydrogen-
abstracting intermediate was a free hydroxyl radical or a 
high-valent iron-oxo complex [35–38]. We became inter-
ested in this topic due to intriguing common features it 
shared with P450s. In 1976, we reported our finding that 
Fig. 1  A variety of biotransformations catalyzed by iron-containing 
oxygenases and their mechanistic features
Fig. 2  Mechanism of aliphatic C–H hydroxylation catalyzed by 
cytochrome P450 (the oxygen rebound mechanism)
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a modified Fenton’s reagent system (Fe2+–H2O2–CH3CN) 
catalyzed the hydroxylation of cyclohexanol affording 
cis-1,3-cyclohexanediol as the major diol product (72%, 
Fig. 3a) [28]. The high regioselectivity and the apparent 
directive effect of the C-1 hydroxyl clearly pointed to an 
iron-mediated hydrogen abstraction, not hydroxyl radical. 
Furthermore, oxidation of trans-3-trans-5-dideuterocy-
clohexanol showed 78% cis-hydrogen abstraction at C-3 
and 96% formation of cis-1,3-diol. This apparent two-stage 
directive effect indicated a stepwise hydrogen abstraction/
radical oxidation sequence involving a coordinated ferryl 
intermediate, FeIV=O (A in Fig. 3b). The excess cis-1,3-
diol could be explained by a trans-C-3 hydrogen abstrac-
tion that then underwent radical oxidation on the syn side 
of the C-1 hydroxyl group (Fig. 3b). Today we know for 
sure that the two-electron oxygenation of ferrous ion by 
ozone produces such a ferryl species [39–43].
Closely following our studies of Fenton’s reagent, we 
initiated a collaboration with colleague Jud Coon to inves-
tigate the mechanism of C–H hydroxylation by rabbit liver 
microsomal cytochrome P450. The idea was to use selec-
tively deuterated norbornane as a mechanistically diag-
nostic substrate for the enzyme. The results showed that 
phenobarbital-induced P450LM2 (now CYP2B4) catalyzed 
the oxidation of exo,exo,exo,exo-2,3,5,6-tetradeuteronor-
bornane (1) at the C-2 position with a significant amount 
of epimerization at the oxygenated carbon (Fig. 4a) [29]. 
We further showed that the hydroxylation of selectively 
deuterated cyclohexene proceeded with substantial allylic 
scrambling (Fig. 4b) [44]. Significantly, synthetic iron por-
phyrin model compounds displayed the same behavior for 
both norbornane and cyclohexene substrates. These dis-
coveries provided strong evidence for a step-wise, noncon-
certed mechanism for C–H scission and subsequent forma-
tion of the new C–OH bond mediated by cytochrome P450 
enzymes. The presence of the intermediate substrate radi-
cal, with a lifetime long enough to epimerize and rearrange 
has turned out to be an important and intrinsic property of 
the oxygen transfer event from oxoiron complexes. A pre-
diction of the rebound process is that the newly formed 
alcohol product should still be coordinated to the heme 
iron. Subsequently, EPR-ENDOR evidence for just such an 
arrangement was provided by Hoffman et al. [45].
The characterization of key intermediates and analysis 
of their reactivity have afforded important insights into the 
nature of enzymatic processes. Much attention has been 
focused on the characterization of the hydrogen-abstract-
ing intermediate compound I, which has been very chal-
lenging due to its highly reactive nature. The compound 
I of other heme-containing proteins such as horseradish 
peroxidase (HRP), catalase, and chloroperoxidase (CPO) 
are much more stable and have been well characterized as 
oxoiron(IV) porphyrin cation radicals [46–51]. However, 
these intermediates are not reactive towards unactivated 
hydrocarbons. Even the compound I of CPO, a heme-
thiolate protein like P450s, can only slowly hydroxylate 
weak benzylic C–H bonds [52]. The first synthetic iron 
porphyrin compound I (species I in Fig. 5a) was character-
ized in 1981. Samples of I were bright green in color and 
displayed the characteristic broad absorbances at 406 and 
645 nm in the visible spectrum of a porphyrin cation radi-
cal. The magnetic susceptibility of I, μB = 4.2, indicated 
Fig. 3  a Hydroxylation of cyclohexanol by Fenton’s reagent. b 
Directive effect in cyclohexanol hydroxylation by Fenton’s reagent 
suggests a coordinated FeIV=O intermediate
Fig. 4  a Oxidation of tetradeuteronorbornane catalyzed by P450LM2. 
b Oxidation of 3,3,6,6-tetradeuterocyclohexene catalyzed by P450s 
and synthetic iron porphyrins
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an S = 3/2 system, while the β-pyrrole protons were 
observed at very high field, δ = −27. The Mössbauer spec-
trum displayed a characteristic doublet at 0.05 mm/s with 
quadrupolar splitting ∆Eq = 1.49 mm/s [53]. This com-
plex, as well as HRP compound I, was shown to have a 
short Fe=O bond distance of 1.65 Å by EXAFS spectros-
copy [54], cementing the assignment of I as an oxoiron(IV) 
porphyrin cation radical. Significantly, I showed high oxy-
gen transfer reactivity towards olefins, affording epox-
ides even at low temperature. Notably, the generation of 
I with peroxyacids in the presence of 18O-water led to sig-
nificant incorporation of the oxygen label into the epoxide 
products, indicating fast iron-oxo exchange with water: 
(TMP·+)FeIV=O + H218O ⇆ (TMP·+)FeIV=18O + H2O. 
Hydroxylation of even the strong C–H bonds of alkanes 
was also achieved in those initial studies [55, 56]. It was 
observed at that time that the hydroxylation product dis-
tribution was very sensitive to the steric bulk of the iron 
porphyrin meso-substitution. This regioselectivity led us to 
propose that hydrogen atom abstraction from the substrate 
occurred through the singly occupied ferryl π* antibond-
ing orbitals as depicted in the original, hand-drawn format 
(Fig. 5b).
Reactive high-valent metal-oxo porphyrins of manga-
nese, chromium, and ruthenium have also been isolated and 
characterized [55, 57–61]. In particular, oxomanganese(V) 
porphyrin complexes displayed very high rates for oxygen 
transfer reactions in aqueous solution [62, 63]. Recently, 
the compound I analog of a highly electron-withdrawing, 
water-soluble iron porphyrin, [4-TMPyP·+]FeIV=O, was 
prepared and shown to exhibit rate constants comparable to 
those of cytochrome P450 for benzylic C–H hydroxylation 
(Fig. 6) [64].
In spite of these close analogies, the lack of direct spec-
troscopic and kinetic characterization of a P450 compound 
I led to proposals of other intermediates such as iron(V)oxo 
and ferric hydroperoxo as alternative hydrogen-abstracting 
intermediates for P450s [65–67]. The long-sought P450 
compound I was finally captured in 2010. Using freeze-
quench techniques, Rittle and Green successfully obtained 
the compound I of CYP119 in high yield [68]. The near-
zero chemical shift of the iron in the Mössbauer spectrum, 
the doublet electronic ground state signaled by the EPR 
spectrum, the weakened and blue-shifted Soret band in 
the UV, and a long-wavelength absorbance in the visible 
near 700 nm explicitly showed that CYP119-I is indeed an 
oxoiron(IV) porphyrin cation radical. These spectral signa-
tures are reminiscent of those found in the first synthetic 
ferryl porphyrin cation radical (species I, Fig. 5) as well as 
the reactive [4-TMPyP·+]FeIV=O. CYP119-I was highly 
reactive toward unactivated C–H bonds with an apparent 
rate constants in the range of 104–107 M−1 s−1. In 2012, 
a second reactive compound I was characterized by our 
group for the extracellular heme-thiolate aromatic peroxy-
genase from Agrocybe aegerita (AaeAPO) [69, 70]. These 
newly discovered fungal peroxygenases, now called unspe-
cific peroxygenases (UPO), are only distantly related to 
chloroperoxidase according to their amino acid sequences, 
and completely unrelated to CYP enzymes, although the 
proximal ligand environment, including peptide N–H 
hydrogen bonding to the heme-thiolate sulfur, is very simi-
lar [71]. AaeAPO-I showed fast rate constants for substrate 
hydroxylations for C–H bonds up to 100 kcal/mol in the 
Fig. 5  (TMP+·)FeIV=O, the first model compound I: a structure of 
oxoiron(IV)TMP radical cation; b depiction of (TMP+·)FeIV=O from 
reference 56 and its Mössbauer spectrum, which indicates high-valent 
iron
Fig. 6  A highly reactive model ferryl porphyrin cation radical of an 
electron-withdrawing iron porphyrin, ref 64
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range of 10–105 M−1 s−1 [69, 70], confirming compound I 
as the intermediate for hydrogen atom abstraction of heme-
thiolate hydroxylases.
Another key intermediate in P450-catalyzed hydroxy-
lations is the hydroxoiron(IV) complex (compound II), 
often called the rebound intermediate [72]. The ferryl 
basicity of compound II that leads to the FeIVO–H struc-
ture has attracted considerable interest. From insights 
developed by Bordwell [73, 74] and applied more recently 
to metal-oxo species by Mayer [75, 76], the O–H bond 
strength (D(O–H)) of compound II can be determined 
from the one-electron reduction potential of compound 
I and the pKa of compound II using a Hess cycle (eq 1, 
Fig. 7). Mayer showed that the reactivity of metal-oxo 
systems for C–H abstraction was predominantly deter-
mined by the reaction driving force, which for the case of 
C–H bond scission is the free energy difference between 
the C–H bond that is broken and the O–H bond formed 
from the ferryl oxygen [77]. Accordingly, a more basic 
ferryl in compound II translates into a stronger FeIVO–
H bond, thus increasing the driving force for hydrogen 
atom transfer from the substrate. In this context, Green 
suggested that the role of the cysteine thiolate in P450 
catalysis is to “push” electron density onto the ferryl oxy-
gen, thus, making P450 compound II more basic than a 
typical metal-oxo species. This effect would allow for 
the cleavage of strong C–H bonds at biologically viable 
reduction potentials and reduce damage to the protein 
scaffold [78, 79]. Indeed, histidine-ligated heme proteins 
such as myoglobin and horseradish peroxidase appear 
to have non-basic ferryls with estimated pKa less than 4, 
consistent with their slow and ineffective oxidative reac-
tivity (Fig. 7a) [79, 80]. The heme-thiolate protein CPO is 
much more reactive than histidine-ligated heme proteins. 
The pKa of CPO compound II was estimated to be above 
8 (Fig. 7b) [81]. Very recently, Green et al. successfully 
determined the pKa values of two P450s, CYP158, and 
CYP119 [82]. The two enzymes have similarly high com-
pound II pKas (around 12, Fig. 7c), although they have 
very different active site environments.
A highly basic compound II (pKa = 10.0, Fig. 7d) was 
also observed for the heme-thiolate aromatic peroxyge-
nase APO described above [83]. Importantly, the reduction 
potential of APO-I, 1.2 V with respect to the resting ferric 
protein, could also be determined through a Nernst equation 
analysis of its reversible reaction kinetics with chloride and 
bromide ions. This value allowed for the determination of 
the individual, one-electron reduction potentials of APO-I 
and APO-II to be Ecpd I/cpd II = 1.4 V and Ecpd II/ferric = 0.8 V 
at pH 7.0, and our estimate that the O–H BDE of Cys–S–
FeIV–O–H of APO is ∼100 kcal/mol. What this means is 
that for APO, and likely P450 as well, strong aliphatic C–H 
Fig. 7  Equation 1 shows the Bordwell equation that relates the newly 
formed FeO–H bond energy to its pKa and redox potential via a Hess 
cycle. C is a constant depending on the solvent and the electrode. 
For aqueous solution and normal hydrogen electrode, the value of 
C is 57.6 kcal/mol. Figure 2a–d shows the active site structures and 
pKas of compound II for common heme-containing proteins. Active 
site structures were rendered using following structures: a myoglo-
bin (PDB: 2V1H); b aromatic peroxygenase from Agrocybe aegerita 
(AaeAPO, PDB: 2YOR); c chloroperoxidase (CPO, PDB: 2J19); d 
cytochrome P450 (CYP119, PDB: 1IO7). Colors: iron (dark pink), 
nitrogen (blue), oxygen (red), carbon (silver), sulfur (yellow)
190 J Biol Inorg Chem (2017) 22:185–207
1 3
bonds are cleaved by these enzymes rapidly, even though 
there is little or no driving force for the reaction.
Cytochrome P450 is not the only enzyme that utilizes 
high-valent iron-oxo intermediates to effect C–H activa-
tion reactions. Indeed, high-valent iron-oxo complexes are 
widely present as the reactive intermediates for the oxi-
dative catalysis by iron-containing oxygenases [2, 5, 10]. 
A notable example is the superfamily of α-ketoglutarate 
(αKG) dependent non-heme iron(II) dioxygenases, which 
catalyze highly selective aliphatic C–H hydroxylations 
[84]. In the active site of these enzymes, the iron(II) center 
is coordinated facially by two histidines and one carboxy-
late [85, 86], a motif known as the ‘2-His-1-carboxylate 
facial triad’. The consensus mechanism of αKG-Fe(II) 
oxygenases is analogous to that of P450s, in which a high-
valent oxoiron(IV) intermediate, first formed through O2 
activation, abstracts a hydrogen from the substrate [87, 
88]. The incipient substrate radical is then captured by a 
hydroxoferric intermediate, analogous to P450 compound 
II, to afford the hydroxylated product (Fig. 8a).
Another example of enzymes that exploit high-valent 
iron-oxo species for C–H activation are the non-heme dii-
ron hydroxylases. The reactive intermediate for this family 
of enzymes is a bis-μ-oxo-iron(IV) complex called com-
pound Q [89–91]. The compound Q of soluble methane 
monooxygenase (sMMO) has been well characterized [91–
93]. Similar intermediates were also proposed for other 
non-heme diiron enzymes including the ω-hydroxylase 
AlkB, toluene monooxygenase (T4moH), and xylene 
monooxygenase (XylM) [89, 94]. Like compound I in 
P450s, compound Q initiates a hydrogen abstraction/radi-
cal rebound sequence to hydroxylate hydrocarbons, most 
remarkably, even methane with its 104 kcal/mol C–H 
bonds (Fig. 8b). From these various enzymatic reactions, 
it is clear that the radical rebound mechanism is a general 
paradigm in biological C–H oxidations catalyzed by iron-
containing oxygenases, uniting the heme and non-heme 
enzymes.
The intermediacy of substrate radicals 
during C–H activation by iron‑containing 
oxygenases
The characteristic feature of the radical rebound mecha-
nism is the intermediacy of the substrate radical generated 
in the initial hydrogen abstraction step. The properties and 
behavior of the incipient radical (i.e. lifetimes and con-
formational changes) and physical and chemical charac-
teristics of the radical rebound step (i.e. rate constant and 
Fig. 8  a Active site structure of a typical αKG dependent non-heme 
iron(II) dioxygenase, TauD, (PDB: 1OS7) and the mechanism of 
taurine hydroxylation catalyzed by TauD. b Active site structure 
of a representative non-heme diiron hydroxylase, soluble methane 
monooxygenase (sMMO) in reduced state (PDB: 1FYZ) and the typi-
cal mechanism of C–H hydroxylation catalyzed by non-heme diiron 
hydroxylase. Colors: iron (orange), oxygen (red), nitrogen (blue), 
sulfur (yellow)
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stereoselectivity) greatly influence the reaction outcome 
and are of crucial importance for the understanding of 
chemistries involving high-valent iron-oxo complexes. 
However, the transient nature of the substrate radical and 
the radical rebound step involving [Fen−1–OH ·R] has 
generally precluded direct mechanistic studies with com-
mon kinetic and spectroscopic methods. In this regard, 
mechanistically diagnostic substrates, which form radicals 
that undergo changes in stereochemistry or structure after 
hydrogen abstraction, offer a powerful tool to study the 
intermediate radical and the rebound step [95].
The first radical rearrangement studies to probe bio-
logically relevant C–H hydroxylation used norcarane as a 
mechanistically diagnostic substrate and manganese por-
phyrins as the catalyst [55]. Significantly, the 2-norcaranyl 
radical (2) ring-opens to a primary homoallylic radical, 
while the corresponding cation affords the more substi-
tuted cycloheptenyl cation (Fig. 9a). The switch in reaction 
pathways is caused by a kinetic preference for cyclopropyl 
C–C bond cleavage to afford the less stable primary carbon 
radical, while for the cationic pathway thermodynamics 
prevail. Ortiz de Montellano and Stearns applied this type 
of substrate rearrangement probe to cytochrome P450s 
[96]. They found that bicyclo[2.1.0]pentane (3) was oxi-
dized by rat liver microsomes containing the P450 enzyme 
to a mixture of ring opened and unrearranged hydroxyla-
tion products in a ratio of 1:7 (Fig. 9b). Given the known 
ring-opening rearrangement rate constant of 2.4 × 109 s−1 
for 2-bicyclopentanyl radical [97], a first-order rate con-
stant of 1.4 × 1010 s−1 and an intermediate radical lifetime 
of ~70 ps were inferred for the oxygen rebound step. After 
this work, there were extensive radical clock analyses on 
P450s especially using norcarane [32, 98]. Norcarane is 
a very informative probe because the slower radical rear-
rangement rate of 2 × 108 s−1 and, as discussed above, 
radical and cation processes afford different products 
(Fig. 9a) [99]. The application of norcarane to a variety 
of P450s gave radical rebound rates in the range between 
1010 and 1011 s−1 corresponding to radical lifetimes also in 
the picosecond regime [100]. This timing is sufficient for 
many molecular vibrations and rotations but is too short to 
allow radical diffusion out of the enzyme active site. The 
yield of the cation-derived product cycloheptenol varied 
with enzymes but was generally small. A likely origin of 
the carbocation intermediate is an electron-transfer oxida-
tion of the incipient carbon radical that competes with the 
radical oxygen rebound, as will be discussed further below. 
In addition to norcarane, other radical clocks such as 
alkyl-substituted cyclopropanes have also been employed 
to study the mechanism of P450-catalyzed oxidations. 
Rebound rate constants between 1010 and 1011 s−1 were 
generally obtained (Fig. 9c), despite some cases for which 
rate constants above 1012 s−1 were inferred with ‘ultrafast’ 
clocks based on aryl-substituted cyclopropanes [101]. Pos-
sible causes of this inconsistency include variations in the 
intimacy of the radical cage pair, the involvement of dif-
ferent spin states of the rebounding intermediate, and dif-
ferences in the environment experienced by the substrate 
radicals within the confined space of P450 active site [1].
Similar radical-clock studies have also been performed 
on a variety of non-heme iron-containing enzymes that 
showed large variations in substrate radical lifetimes 
(Table 1). For instance, radical lifetimes of diiron-contain-
ing soluble methane monooxygenases (sMMO) [89, 90, 
102, 103], toluene 4-monooxygenase (T4moH) [104, 105], 
and alkane hydroxylase alkB [106–108], were determined 
to be 20, 263 ps, and 1 ns, respectively. A very long radi-
cal lifetime (11 ns) was observed for monooxygenation 
reactions catalyzed by naphthalene dioxygenase (NDO), 
which belongs to the family of Rieske dioxygenases [109]. 
Such variations in radical lifetimes were also observed in 
synthetic model compounds. i.e. with the norcarane radi-
cal clock, hydroxylations catalyzed by synthetic iron por-
phyrins showed radical lifetimes in the order of tens to 
Fig. 9  a Mechanisms of rearrangement of the 2-norcaranyl radical 
and cation intermediates. b Oxidation of bicyclopentane catalyzed by 
liver microsomal P450. c A representative cyclopropane-based radical 
clock probe and radical lifetimes of common cytochrome P450s
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hundreds of picoseconds [110], while reactions catalyzed 
by manganese porphyrins exhibited radical lifetimes in the 
nanosecond regime [55].
The large range of radical lifetimes for various enzymes 
and synthetic model compounds highlights the intricacy 
and inner diversity of the transient radical rebound step of 
[Fen−1–OH ·R]. A fundamental question to ask is what fac-
tors control the radical lifetimes and rebound rate. From a 
thermodynamic perspective, radical rebound is a one-elec-
tron reduction process to the metal center. It is therefore 
not surprising that the metal center as well as the oxida-
tion of the substrate radical intermediate would affect the 
radical rebound rate. This notion is well illustrated by the 
over tenfold increase in radical lifetimes for manganese 
porphyrin-catalyzed aliphatic hydroxylations compared to 
the reactions catalyzed by iron porphyrins (Table 1) [55, 
110]. In sharp contrast, radical intermediates were not 
observed for C–H hydroxylations catalyzed by ruthenium 
porphyrins [110, 111]. Such variations in rebound behav-
ior likely result from the differences in oxidation potentials, 
electronic configurations, as well as the relative energet-
ics of different spin states of the rebounding intermediates 
[111–117].
Further insights are found by considering the frontier 
orbital interactions during the rebound encounter [118, 
119]. Most of our understanding regarding this aspect 
comes from computational studies. A revealing notion 
gained from such studies is the possible involvement 
of multiple spin states and energetic surfaces for oxida-
tions catalyzed by paramagnetic iron-oxo intermediates, 
which was first suggested by Shaik and his colleagues in 
the density functional theory (DFT) analysis of methane 
hydroxylation by a ferryl-porphyrin cation radical [120]. 
They found that the ferryl intermediate had two nearly iso-
energetic electronic configurations, doublet and quartet, 
and thus the C–H abstraction and radical rebound could 
occur along either a high-spin (HS) or a low-spin (LS) tra-
jectory (Fig. 10). Green et al. have shown that P450 com-
pound I adopts a low spin S = 1/2 state [68]. Intriguingly, 
S = 3/2 spin states were generally shown for compound I 
of iron porphyrin model compounds [121]. These experi-
mental findings suggest a facile interconversion between 
the doublet and quartet spin states of compound I. While 
the two pathways showed similar energy barriers for the 
C–H abstraction, the HS pathway exhibited a larger bar-
rier for the radical recombination step. In both pathways, 
the rebound intermediate FeIV–OH adopted an S = 1 spin 
state. On the LS surface, the electron of the substrate radi-
cal is predicted to interact with the singly-occupied iron dxz 
(or dyz) orbital as in Fig. 5b, whereas in the HS pathway, 
the electron transfers into a higher-energy, unoccupied dz2 
orbital, giving rise to the larger rebound barrier for rebound 
along the HS surface. Recently, Shaik further applied this 
multi-state analysis to a number of non-heme metal-oxo 
systems including MnIVO, FeIVO, CrIVO, FeVO, and RuIVO. 
In these cases, the energy barriers of the rebound step were 
also dependent upon the spin states of the pathways [122]. 
The calculated rebound barriers of non-heme complexes 
were much higher than that of the heme intermediate in 
P450s. This result is consistent with the long radical life-
time measured for the non-heme iron dioxygenases and 
may arise from the lower oxidation state of the rebound 
intermediate (FeIII) in non-heme iron complexes.
In addition to the intrinsic properties of the rebound 
intermediates, another important, and often overlooked 
factor that affects the rebound step is the cage effect. After 
the initial hydrogen atom abstraction, the incipient sub-
strate radical and rebound intermediate comprise a caged 
radical pair [Fe–OH ·R]. We note that weak interactions 
between the substrate radical and the iron center at this 
Table 1  Typical radical 
lifetimes of non-heme iron 
enzymes and synthetic 
metalloporphyrins determined 
by norcarane
a Tetramethylcyclopropane (TMCP) was used as radical clock substrate
T4moH sMMO AlkB NDO Mn(TMP)OAc Fe-4-TMPyP
[U]/[R] 19 240 5.3 0.34 15.2 6
τ 263 ps 20 ps 1 ns 11 ns 330 ps 81 psa
Fig. 10  Energy profile and reaction coordinate for the methane 
hydroxylation by a ferryl-porphyrin cation radical. The figure is 
adapted from Ogliaro et al. [120]
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stage would facilitate spin state interconversions for the 
ensemble. Another important feature of such caged radi-
cal species is the competition between the in-cage radical 
recombination and the diffusive cage escape. In an enzyme 
active site a water molecule, or a protein functional group, 
can insert itself between the substrate radical and the metal 
center as in [Fe–OH···OH2·R]. There is abundant photo-
physical evidence for competitive cage-escape and recom-
bination as stochastic events in radical reactions since their 
initial discovery in 1930s [123]. A compelling example is 
the homolytic cleavage of carbon-cobalt bond in 5′-deoxy-
adenosylcobalamin (coenzyme B12) to form cobalt(II)-
cobalamin and an adenosyl radical, which is important 
for the biological functions of coenzyme B12-dependent 
mutase enzymes. Time-resolved spectroscopic studies 
showed that the initial radical pair formed after Co–C 
bond homolysis in adenosylcobalamin undergoes in-cage 
radical recombination and cage escape both at approxi-
mately 109 s−1, clearly indicating a competition between 
the two processes [124–126].
The realization of the significant influence of cage 
effects in radical rebound processes came from our studies 
of synthetic heme-model compounds. In 1979, we reported 
the first synthetic iron porphyrin system that effected ste-
reospecific alkane hydroxylation and olefin epoxidation 
[127]. Further examination of this reaction showed that 
in the presence of a radical trap, bromotrichloromethane, 
an 18% yield of the bromination trapping product was 
obtained [56]. This result clearly indicated the presence 
of the cage escaped substrate radical that had encountered 
BrCCl3 in solution.
The competition between cage escape and in cage 
recombination would offer an explanation to an enigma 
observed during the radical clock analysis of alkB, in 
which radical clock substrates with different rearrangement 
rate constants gave substantially different radical lifetimes 
(Fig. 11a) [107]. As shown in Fig. 11, three radical clocks, 
bicyclopentane, norcaranane, and bicyclo[3.1.0]hex-2-ane 
showed similar ratios of rearranged to unrearranged prod-
ucts (R/U) (1.6, 1.6, and 4.7), corresponding to apparent 
radical lifetimes of 0.78, 7.8, and 170 ns. These seemingly 
contradictory and counterintuitive results can be accommo-
dated by a mechanism involving the diffusive cage escape 
of the substrate radical within the rather long enzyme active 
site to a solvent-separated radical pair, RPss (Fig. 11b) 
[108]. If the cage escape of the substrate radical occurs at a 
rate constant (ke) comparable to the rebound rate (kR), then 
for clocks with radical rearrangement constants (kr) slower 
than ke, the R/U ratios would not be much affected by the 
differences in kr but reflect the “caging efficiency” ke/kr. 
This effect is analogous to the commonly observed sup-
pression of the kinetic hydrogen isotope effects by strong 
binding of the substrate. The value of ke is not expected to 
be constant because it will be substantially affected by the 
environment, such as viscosity of the solvent, tightness of 
the radical cage, steric and electronic environment within 
the active site and associative interactions of the substrate 
with the enzyme. An example is the large effect of substrate 
concentration on apparent 2-norcaranyl radical lifetime 
for AlkB. In this case, the presence of additional substrate 
molecules could displace and reorganize active-site water 
creating a bulkier hydrophobic environment that reduces ke 
and facilitates the recombination of the initial radical pair. 
An important lesson learned here is that while diagnostic 
Fig. 11  a Oxidation of radical clock probes with different rearrange-
ment rate constants by non-heme diiron hydroxylase AlkB. b Sche-
matic illustration of geminate recombination and cage escape. The 
scheme is adapted from Austin et al. [107]
Fig. 12  Catalytic cycle of metMb-catalyzed peroxynitrite decompo-
sition
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substrates can be used to detect the presence of intermedi-
ate radicals, the observed R/U ratios do not reflect the rate 
of rebound step in a simple way.
There are only a few studies on cage escape effects in 
P450-catalyzed hydroxylations [110]. But the degrada-
tion of peroxynitrite catalyzed by myoglobins provides an 
example to understand the cage escape/recombination pro-
cesses in the context of the ferryl intermediates of heme-
proteins (Fig. 12) [128, 129]. Myoglobins react rapidly 
with peroxynitrite to form a radical pair of a compound II 
ferryl intermediate and NO2, [MbFe
IV=O ·NO2]. This radi-
cal pair can undergo recombination to form FeIII-heme and 
nitrate with rate constant kr, or NO2 can diffuse away from 
the distal heme site with rate constant ke. One manifesta-
tion of freely diffusing NO2 in this scenario is to induce 
tyrosine nitration elsewhere (i.e. in protein scaffold). This 
process is reminiscent of the recombination and escape 
events of deoxymyoglobin with O2, CO, and NO. The for-
mation of MbFeIV=O was directly observed in these stud-
ies by stopped-flow spectrophotometry and a chemical trap, 
fluorescein, was used to capture the freely diffusing NO2. 
Based on these measurements, kinetic simulations revealed 
10% cage escape of NO2 and ke/kr = 0.10. Curiously, the 
reaction of oxymyoglobin with NO, which could have 
afforded the same peroxynitrito-iron(III) intermediate, did 
not afford detectable intermediates [130].
Very recently, Shaik and Nam have examined the cage 
escape/radical rebound processes for a number of non-
heme metal-oxo systems [122]. They found that cage 
escape pathways generally showed low calculated energy 
barriers that could well compete with the in-cage radi-
cal recombination processes. In several cases, such as 
[MnIVO(Bn-TPEN)]2+ and [FeIVO(Bn-TPEN)]]2+ (Bn-
TPEN = N-benzyl-N,N′,N′-tris(2-pyridylmethyl)-1,2-
ethylenediamine), radical cage escape was found to be 
the preferred pathway and the diffusing radicals could be 
trapped by radical scavengers such as CCl3Br, N-bromo-
succinamide, or O2 under aerobic conditions [131–134].
Radical rebound mechanism: a reaction 
manifold for versatile biotransformations other 
than oxygenation
The stepwise events of hydrogen abstraction and radi-
cal recombination in the rebound mechanism represents a 
general strategy exploited by nature to perform controlla-
ble radical reactions. As discussed in the previous section, 
the behavior of the incipient substrate radical is highly tun-
able. As such, the initial substrate radical can be employed 
in a variety of radical processes and lead to different reac-
tion outcomes. In this context, oxygen rebound of sub-
strate radicals to form a C–OH bond represents just one 
type of possible reactions enabled by the radical rebound 
mechanism. Indeed, nature has found ways to manipulate 
the behavior of the incipient radicals for chemistries other 
than oxygen rebound. Early examples include prostaglan-
din H synthase and lipoxygenase, in which incipient sub-
strate radicals are trapped by oxygen to afford the hydrop-
eroxy products (Fig. 13, pathway E). In these cases there 
are discrete oxygen-binding pockets within the protein that 
control the substrate radical rebound to a nearby oxygen 
molecule.
In addition to these two enzymes, there are numer-
ous examples described during the past decade highlight-
ing the versatile reactions that incipient substrate radicals 
could participate. For example, diversion of the rebound 
intermediate to form olefins can be seen as a hydrogen 
atom rebound to the FeIV–OH [32]. Another example is 
the conversion of fatty acids to terminal alkenes catalyzed 
by cytochrome P450 OleTJE (Fig. 14). Since its discovery 
in 2011, this biotransformation has garnered considerable 
attention due to its potential applications in biofuel and fine 
chemical synthesis [135–137]. The studies of Makris et al. 
showed that the mechanism of OleTJE-catalyzed decarbox-
ylation involved an initial hydrogen abstraction by OleTJE 
compound I as in P450-catalyzed hydroxylations at the β 
carbon relative to the carboxyl group [138, 139]. This result 
is intriguing, as it suggests that the usual oxygen rebound 
step must be inhibited in the case of OleT and the incipient 
radical is redirected to a C–C bond scission pathway, pre-
sumably involving single electron transfer from substrate 
radical to compound II and subsequent loss of CO2 to form 
C=C bond. Such electron transfer processes to form sub-
strate cation intermediate have also been reported recently 
for CYP161C2 (PntM), which catalyzes an oxidative rear-
rangement reaction that converts pentalenolactone F to 
pentalenolactone (pathway C, Fig. 13) [140].
Computational studies by de Visser et al. also suggested 
a slow-down of the radical rebound for OleT [141]. An 
8 kcal/mol energy barrier was estimated for the oxygen 
rebound of substrate radical to OleTJE compound II, while 
the energy barrier of the decarboxylation pathway was esti-
mated to be below 1 kcal/mol. The calculation also sug-
gested that hydrogen bonding interactions within the P450 
OleTJE active site are essential for the destabilization of the 
oxygen rebound.
An analogous example to P450 OleTJE-catalyzed decar-
boxylation is the iconic side chain C–C bond scission reac-
tion catalyzed by cytochrome P450SCC, which converts 
cholesterol to pregnenolone. P450SCC first performs two 
successive hydroxylations of cholesterol to form 20α,22(R)-
dihydroxycholesterol (DHC) (Fig. 15a). In the third step, 
P450SCC compound I abstracts the hydrogen from the C22 
hydroxyl group to form a C22-oxy radical and compound 
II. The C22-oxy radical then undergoes C20–C22 bond 
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homolysis to afford isocaproaldehyde and a C20 ketyl 
radical that recombines with compound II to afford pregne-
nolone [142]. Recent reevaluation of the activity of steroid 
aromatase CYP19A1 also suggests a mechanism involving 
the redirection of the oxygen rebound (Fig. 15b) [143]. In 
this mechanism, the radical intermediate generated after 
the initial hydrogen abstraction undergoes one-electron 
transfer to form a cation in the A ring of androgen, which 
subsequently aromatizes to form the estrogen. From these 
examples, it is clear that the radical pair [Fe–OH ·R] gener-
ated after the initial C–H bond cleavage follows different 
reaction channels leading to novel reactivities other than 
oxygenation.
Steering radical rebound is also widely exploited in non-
heme iron enzymes. A compelling example is the formation 
of isopenicillin N from δ-(l-α-aminoadipoyl)-l-cysteinyl-d-
valine (ACV) catalyzed by isopenicillin N synthase (IPNS) 
(Fig. 16), which is a key step in the biosynthesis of peni-
cillin and cephalosporin antibiotics [144]. IPNS is a non-
heme iron(II)-dependent oxygenase with an active site con-
taining an iron coordinated to a 2-His-1-carboxylate facial 
triad. The elegant work of Baldwin and co-workers showed 
that two stages were involved for the formation of isopeni-
cillin N from ACV [144]. The first stage involves the for-
mation of the β-lactam ring and an FeIV=O intermediate. 
Fig. 13  Generation of the radical pair via hydrogen atom abstraction and the various reaction outcomes depending on the behavior of the radical 
pair
Fig. 14  Oxidative decarboxylation catalyzed by OleTJE
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In the second stage, the FeIV=O intermediate abstracts a 
hydrogen from the valinyl C3–H and the resulting C3 car-
bon radical recombines with the iron-bound sulfur to gener-
ate the thiazolidine ring, a process analogous to the oxygen 
rebound in oxygenation reactions [145]. The involvement 
of the radical intermediate in this process was illuminated 
by employing a cyclopropane-containing ACV analog and 
observation of a rearranged product of the cyclopropylcar-
binyl radical [146]. The result that IPNS selectively forms a 
C–S bond rather than C–O bond during the radical rebound 
step is intriguing, as the C–S bond is much weaker than the 
C–O bond. The DFT studies by Morokuma et al. on IPNS 
active-site models showed that, although the formation of 
hydroxylation product is more thermodynamically favora-
ble, the C–S bond formation is kinetically favored as the 
transition state for sulfur rebound is 3.7 kcal/mol lower 
than oxygen rebound barrier [147–149].
Aliphatic C–H chlorination reactions catalyzed by 
α-ketoglutarate (αKG) dependent non-heme iron(II) halo-
genases represent another example of non-oxygen atom 
rebound. The first Fe(II)/αKG halogenase discovered is 
the halogenase SyrB2, which catalyzes the C4 chlorina-
tion of threonine appended to the carrier protein SyrB1 
(l-Thr-SyrB1) during the biosynthesis of syringomycin 
E by Pseudomonas syringae (Fig. 17) [150]. Structural 
studies showed that, in Fe(II)/αKG halogenases, the fer-
rous center is coordinated to two histidines and a chloride 
instead of the 2-His-1-carboxylate coordination in a typical 
Fe(II)/αKG hydroxylase [151]. A conserved alanine or gly-
cine was found at the position of aspartate or glutamate in 
Fe(II)/αKG hydroxylase which created the space for chlo-
ride binding. The mechanism of Fe(II)/αKG halogenases 
involves a chloroferryl intermediate (Cl–FeIV=O) that 
abstracts a hydrogen atom to form a substrate radical and a 
chlorohydroxoferric intermediate (Cl–FeIII–OH). The sub-
strate radical then rebounds to the chlorine to afford chlo-
rination product.
The factors leading to the preference for chlorine over 
hydroxyl transfer during the rebound scenario has attracted 
Fig. 15  a Mechanism of the C–C scission of DHC catalyzed by 
P450SCC. b Proposed mechanism of the aromatization step in the con-
version of androgens to estrogens catalyzed by CYP19A1
Fig. 16  Mechanism of IPNS-catalyzed formation of isopenicillin 
from ACV
Fig. 17  Mechanism of C–H chlorination catalyzed by SyrB2 (PDB: 
2FCT). Colors: iron (magenta), oxygen (red), nitrogen (blue), chlo-
rine (green)
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considerable attention. A number of studies involving 
spectroscopic and structural analysis as well as reactivity 
assays using native substrate analogs show that a closer 
positioning of the substrate radical to the chlorine during 
the rebound is an important factor in determining the chlo-
rination selectivity [152–158]. Very recently, Boal and Liu 
obtained the first substrate-bound crystal structure of a car-
rier protein-independent Fe(II)/αKG halogenase, WelO5, 
which chlorinates 12-epi-fischerindole U at the C13 posi-
tion [159–161]. The crystal structure indicated a reloca-
tion of the oxo unit from the axial position to the equato-
rial plane defined by the chloride and the αKG, which 
would draw the oxo group further way from the substrate 
(Fig. 18). This transition is apparently aided by a hydrogen-
bonding interaction with the hydroxyl group of Ser189 in 
the Fe(II) secondary sphere. Mutation of Ser189 to alanine 
led to an equal portion of hydroxylation and chlorination 
products.
Chlorination is not the only reaction that Fe(II)/αKG 
halogenase could effect. Recently, Bollinger and co-work-
ers found that Fe(II)/αKG halogenases could catalyze C–H 
azidation and nitration upon replacing the iron-bound chlo-
ride with azide and nitrite [162]. Analogous to the chlo-
rine rebound scenario in halogenases, the incipient radical 
formed after initial C–H abstraction by FeIV=O recom-
bined with an azidoferric (N3–Fe
III–OH) or a nitritoferric 
(NO2–Fe
III–OH) intermediate to form the C–N3 or C–NO2 
bond, albeit in modest conversions.
Non-heme iron oxygenases can also catalyze other non-
oxygenation reactions by employing substrate radicals in 
different radical processes. An interesting example is the 
transformation of 2-hydroxyethylphosphonate (2-HEP) to 
different products by enzymes sharing a similar mechanism 
[163–165]. As shown in Fig. 19, 2-HEP can be converted 
to methylphosphonate (MPn) by MPn synthase (MPnS) or 
to hydroxymethylphosphonate (HMP) by 2-HEP dioxy-
genase (HEPD). These two reactions proceed through a 
common radical intermediate (species III in Fig. 19a). In 
HEPD, HMP was obtained by the oxygen rebound of the 
methylphosphonate radical to the FeIII–OH complex (IV 
in Fig. 19a), whereas in MPnS, the methylphosphonate 
radical will abstract a hydrogen from the formate to afford 
MPn (V in Fig. 19a).
An analogous example of HEPD and MPnS is 
2-hydroxypropylphosphonate epoxidase (HppE) [166–
170]. HppE is involved in the biosynthesis of the antibiotic 
fosfomycin from (S)-2-hydroxypropylphosphonate (2S-
HPP). In this reaction, an oxoferryl intermediate is formed 
prior to the epoxide formation step that abstracts the pro-R 
hydrogen from C1 of 2S-HPP. Subsequent electron transfer 
from the C1 radical to FeIII–OH and epoxide ring closure 
afford the fosfomycin product (Fig. 19b).
In addition to the examples discussed herein, there are 
a number of other reactions that can be effected by iron 
oxygenases via controlling the reaction pathways of incipi-
ent radicals, including stereoinversion, oxacyclization, 
carbodesaturation, etc. In another variation of the rebound 
Fig. 18  a C–H Chlorination of 12-epi-fischerindole U catalyzed by 
the halogenase WelO5. b Relocation of the iron-oxo unit in the for-
mation of oxoiron(IV) intermediate. c Active site structure of WelO5 
(PDB: 5IQT). Colors: iron (orange), oxygen (red), nitrogen (blue), 
chlorine (green)
Fig. 19  a Synthesis of HMP and MPn from 2-HEP catalyzed by 
HEPD and MPnS respectively. b Synthesis of fosfomycin from 
2S-HPP catalyzed by HppE
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spectrum of reactions, aldehyde deformylation by the dii-
ron enzyme ADO produces alkanes in a process that can 
be seen as a hydrogen rebound from Fe–OH2 [171]. These 
reactions have recently been reviewed by Bollinger and 
Krebs [172]. The common feature of these biotransfor-
mations is the involvement of an initial hydrogen atom 
abstraction by high-valent iron-oxo intermediates. The 
desired reaction outcome is achieved by directing the incip-
ient substrate radicals to the corresponding radical reac-
tion pathways such as oxygen rebound, non-oxygen atom 
rebound, electron transfer, radical cage escape, etc. In this 
way, nature can achieve a diverse array of C–H transforma-
tions with molecular oxygen as the oxidant by employing 
these aspects of the rebound process.
Harnessing the radical rebound mechanism 
for novel organic radical transformations 
through biomimetic catalysis
The direct functionalization of aliphatic C–H bonds 
remains one of the grand challenges for the chemical catal-
ysis community [173]. Activation of aliphatic C–H bonds 
with organometallic reagents, such as Shilov chemistry 
or many Pd-catalyzed C–H functionalizations, generally 
requires harsh conditions or utilizes a directing group 
approach because of the low acidity and weak coordina-
tion capability of aliphatic C–H bonds [174–177]. On the 
other hand, it has been long recognized that direct function-
alization of aliphatic C–H bonds can be achieved via radi-
cal chemistry [178–180]. A classic example is the radical 
chlorination of hydrocarbons with Cl2 under photolytic or 
thermal conditions, which have been used for the industrial 
synthesis of chloroform and dichloromethane from meth-
ane [181]. The power of radical C–H activation has been 
further demonstrated by the recent renaissance of catalytic 
radical-based methods, especially photoredox catalysis that 
has provided a variety of new methods for aliphatic C–H 
functionalization reactions [182–184].
In this context, the radical rebound strategy employed 
by iron-containing oxygenases represents a novel and 
general paradigm for effecting direct aliphatic C–H func-
tionalizations. There are three main features that set this 
biological approach apart from other radical C–H activa-
tion methodologies (Fig. 20). First, the C–H activation is 
mediated by first-row metal complexes such as metal-oxo 
intermediates instead of organic or inorganic radicals com-
monly seen in radical reactions. The use of metal-based 
Fig. 20  Comparison between 
common radical C–H function-
alizations (a) and those medi-
ated by iron oxygenases and 
their model compounds (b)
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hydrogen abstracting intermediates enables the control of 
regioselectivity of C–H activation beyond the innate reac-
tivity of C–H bonds. With this approach, stronger primary 
or secondary C–H bonds can be selectively functionalized 
in the presence of much weaker tertiary C–H bonds. Sec-
ond, in a radical rebound approach, the new bond forma-
tion step of carbon-centered radical also proceeds through a 
metal-based intermediate, allowing for highly stereoselec-
tive trapping of the carbon-centered radicals. This feature 
resembles several photoredox reactions in which a nickel or 
copper catalyst can trap the alkyl radicals and effect enan-
tioselective C–C or C–N bond formations. Another feature 
of the radical rebound approach is the controlled genera-
tion of carbon-centered radicals rather than radical chain 
mechanisms for many organic radical transformations. In 
biology, this feature is critical as freely diffusing carbon 
radicals are harmful to the biological system. This charac-
teristic is also desired for organic transformations as it will 
eliminate unwanted side reactions.
There are many catalytic systems for aliphatic C–H 
hydroxylation reactions based on synthetic models of Fe-
containing oxygenases, which have been reviewed exten-
sively [17, 18, 185]. Herein, we will mainly focus on non-
oxygenation reactions via the radical rebound mechanism, 
which has offered solutions to several most challenging 
reactions in synthetic organic chemistry.
The first hint of such nonoxygenation reactions was 
obtained during our investigation of synthetic models for 
P450s. In 1980, we found that manganese porphyrins can 
effect highly efficient alkane hydroxylations. In this reac-
tion, side chlorination products were also observed, which 
were determined to derive from the chloride axial ligand on 
the manganese porphyrin catalyst [55]. The mechanistically 
diagnostic radical clock norcarane used in that study clearly 
showed the presence of the radical rearranged chlorination 
product, 3-chloromethyl-cyclohexene. This chlorination 
product was formed through a hydrogen abstraction/radical 
rebound pathway with a radical lifetime of ~25 ns (Fig. 21a). 
Subsequent studies by our group and the Hill group showed 
that a variety of axial ligands, including bromide, iodide, and 
azide, could undergo this oxidative ligand transfer reaction 
[186–188]. Meunier and coworkers also found that manga-
nese porphyrin/NaOCl system could effect C–H chlorination 
of cyclohexane [189]. In 1993, Que and co-workers dem-
onstrated that such ligand transfer reaction also occurred 
with non-heme iron complexes [190]. Very recently, several 
oxoiron(IV) non-heme complexes with a cis-coordinated 
chloride ligand have been examined because of their resem-
blance to the halogenation intermediate of iron halogenases 
(Fig. 21b) [191–193]. Reactivity studies revealed that some 
of these complexes can effect aliphatic C–H chlorination with 
a ratio of oxygenation to halogenation varying from ~1 to ~6.
Fig. 21  a Detection of the 
chlorination product in alkane 
hydroxylation catalyzed by 
a manganese porphyrin. b 
Halogenation reactivity of 
several non-heme iron model 
compounds
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A standing challenge for implementing the radical 
rebound approach for catalytic C–H functionalization has 
been the suppression of the oxygenation products formed 
via oxygen rebound. The first breakthrough was achieved 
in 2010, when we discovered an unusual manganese 
porphyrin-catalyzed aliphatic C–H chlorination reaction 
(Fig. 22) [194]. With sodium hypochlorite as the oxidant 
and chlorine source, a variety of hydrocarbons were readily 
chlorinated with only trace amount of oxygenation prod-
ucts. Product selectivities were very much different than 
those of typical chlorination reactions. The chlorination 
of trans-decalin, for example, afforded mainly secondary 
chlorination products (2°/3° > 9), which is in drastic con-
trast to the chlorination of the same substrate with N-chlo-
rosuccinimide (NCS) or hypochlorous acid (2°/3° ratio 
~0.7 and 0.3). Furthermore, the sterically bulky Mn(TMP)
Cl catalyst yielded chlorination products with a C3/C2 ratio 
of 4, much higher than that of the less sterically hindered 
Mn(TPP)Cl (C3/C2 = 0.65). These results demonstrated 
that the regioselectivity of these radical C–H chlorination 
reactions can be regulated by the steric and electronic prop-
erties of the catalyst, hints of which were seen in the very 
early hydroxylation work (Fig. 6) [55, 56]. This catalytic 
chlorination also showed high stereoselectivities during 
the chlorine transfer step. For example, 5α-cholestane was 
selectively chlorinated at C2 and C3 positions with equato-
rial to axial ratio of 15:1 and 1:2, respectively.
Radical clock studies showed that the reaction followed 
a radical mechanism with a radical lifetime ~11 ns, which 
is much longer than that of the analogous hydroxylation 
(~2 ns). No cation rearranged product was observed, which 
further indicated a radical rebound mechanism.
An intriguing question is what slows down the oxy-
gen rebound and inhibits the oxygenation products in this 
chlorination reaction. Later studies showed that the axial 
ligand played an important role in determining the radical 
lifetime of the incipient carbon radicals (Fig. 23). The addi-
tion of strongly ligating imidazole or pyridine to the chlo-
rination system significantly suppressed chlorination and 
led to oxygenation products instead [195]. This axial ligand 
effect was further supported by the radical clock analysis 
of the Mn-catalyzed hydroxylation reaction in which radi-
cal lifetime increased significantly by changing the axial 
ligand from imidazole or pyridine to anionic σ-donating 
ligands hydroxide and fluoride.
This unprecedented axial ligand effect on radical 
rebound offered a general strategy to develop biomimetic 
radical C–H functionalization reactions that nature had 
not yet devised via the control of the radical rebound step 
(Fig. 24). A good demonstration of this approach is the 
development of an unprecedented aliphatic C–H fluori-
nation with fluoride ion developed by our group in 2012 
[196]. The rationale of this reaction is that the addition 
of fluoride ion would suppress oxygen rebound and the 
incipient radical could be redirected to recombine with a 
MnIV–F intermediate in a process that resembles oxygen 
rebound. Although there are many examples of radical 
fluorination based on electrophilic fluorination reagents 
[197–200], radical fluorination with fluoride-derived Mn–F 
Fig. 22  Aliphatic C–H chlorination catalyzed by manganese porphy-
rins
Fig. 23  Effect of axial ligands on the oxygen rebound step
Fig. 24  The concept of heteroatom rebound catalysis (HRC) for 
developing C–H functionalization reactions
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rebound was unprecedented. A significant challenge to 
developing fluoride-based radical fluorination lies in the 
high oxidation potential of fluoride ion that typically pre-
vents it from participating in redox chemistry [201–203]. 
We found that binding of fluoride ion to a manganese(IV) 
porphyrin activated it toward fluorine atom transfer to the 
substrate alkyl radical. To probe this idea, a unique trans-
difluoromanganese(IV) porphyrin complex was synthe-
sized and isolated. Treating this species with radical pre-
cursors generated under thermolytic conditions afforded 
alkyl fluoride products via radical trapping in high yields 
(Fig. 25).
With this mechanistic insight in hand, we developed 
the first fluoride-based aliphatic C–H fluorination reaction 
(Fig. 26a) [196]. Like the manganese porphyrin-catalyzed 
chlorination, this reaction showed catalyst-controlled regi-
oselectivity with a preference for secondary aliphatic C–H 
bonds in the presence of weaker tertiary C–H bonds. High 
regio- and stereo-selectivity were achieved for a number of 
complex substrates including the terpenoid sclareolide and 
a steroid, 5α-androstan-17-one. Radical clock studies again 
showed a radical rebound mechanism with radical lifetimes 
of ~2 ns. Highly selective benzylic C–H fluorination was 
achieved by changing the catalyst to manganese salens 
(Fig. 26b). When using a chiral manganese salen catalyst, 
a 20% ee was detected for the fluorination of celestolide. 
This small but mechanistically revealing enantioselectiv-
ity led strong support for the radical rebound to a catalyst-
bound Mn–F intermediate. DFT calculations to probe this 
process predicted a very low energy barrier (~3 kcal/mol) 
for such a fluorine rebound process from manganese.
The use of fluoride ion in this C–H fluorination reac-
tion allowed us to develop the first 18F labeling reaction 
of aliphatic C–H bonds using [18F]fluoride, which could 
have wide applications in positron emission tomography 
(PET) (Fig. 27) [204]. [18F]fluoride is the preferred 18F 
source for molecular labeling with 18F for PET because 
of its high specific activity (a measure of 18F/19F ratio in 
the labeled molecules) [205]. The major challenge of this 
labeling reaction is the short half-life of the 18F radionu-
clide (~110 min) and its minuscule quantities (pmol–nmol) 
under typical radiochemical process conditions [206, 207]. 
We found that manganese salen catalysts with a labile 
tosylate ligand could efficiently trap pmol of 18F in the 
solution with over 90% efficiency. With this approach, 
Fig. 25  Trapping of alkyl radicals by trans-MnIV(TMP)F2 via fluo-
rine atom transfer. X-ray crystal structure of trans-MnIV(TMP)F2 
drawn at 50% probability of the electron density with following atom 
colors: F (yellow), Mn (magenta), N (blue), C (cyan) (H atoms are 
omitted for clarity)
Fig. 26  a Aliphatic C–H fluori-
nation catalyzed by manganese 
porphyrins. b Benzylic C–H 
fluorination catalyzed by mag-
nanese salens
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our labeling method effects efficient C–H 18F labeling of 
a variety of substrates including nine complex drug mol-
ecules or drug analogs within 10 min with very practical 
radiochemical conversions (conversion of 18F into the tar-
get molecule) up to 70%. Mechanistic studies showed that 
this reaction also proceeded through an H-abstraction/
fluorine rebound mechanism as a 25% ee was observed for 
the 18F labeling of celestolide with chiral manganese salen 
catalyst. The success of this 18F labeling reaction provided 
critical insight to the fluorine rebound step. It is worth not-
ing that in 18F reactions, all other reactants, including the 
manganese ‘catalyst’, are in vast excess because of the tiny 
quantity of 18F fluoride (pmol). Therefore, the concentra-
tion of the MnIV–18F intermediate would be much lower 
that of MnIV–OH intermediate. However, the observed high 
18F conversion into target molecule suggests that the radical 
rebound to MnIV–18F must be highly selective in capturing 
incipient alkyl radicals.
The radical rebound approach is not only restricted to 
carbon–halogen bond formation reactions. Azide is another 
important functionality that has versatile applications in 
organic synthesis and biorthogonal chemistry [208, 209]. 
Azide transfer from metal-azide complexes to alkyl radicals 
is well known [210, 211]. We developed a manganese-cata-
lyzed late-stage aliphatic C–H azidation reaction following 
the chemical logic of H abstraction/azide rebound (Fig. 28) 
[212]. Radical clock studies showed that the radical life-
time of this reaction was around 30 ns, significantly longer 
than what was observed for chlorination and fluorination. 
The azidation of celestolide with a chiral manganese salen 
catalyst afforded product in 70% ee, which is much higher 
than that of fluorination. DFT calculations showed that the 
azide transfer from MnIV–N3 to an alkyl radical adopted a 
bent geometry for all reaction pathways because of the lin-
ear shape of azide, whereas the lowest-energy pathway of 
fluorine transfer showed a linear σ-geometry, pushing alkyl 
radicals away from the steric environment of the ligand, 
leading to low enantioselectivity (Fig. 29).
This series of unprecedented radical C–H functionali-
zation reactions share common features and mechanistic 
foundations. They are all initiated by hydrogen abstraction 
via oxoMnV intermediates, which give rise to the tunable 
regioselectivity that can surpass the restriction of innate 
reactivity of aliphatic C–H bonds. The oxygen rebound in 
these reactions are all suppressed due to the presence of 
strong anionic σ-donating ligands. Although more studies 
are needed to further elucidate the nature of non-oxygen 
rebounding intermediate, radical clock studies with nor-
carane showed long radical lifetimes (~2 ns for fluorina-
tion, ~10 ns for chlorination, and ~30 ns for azidation). The 
long radical lifetime seems to be crucial for the success 
of non-oxygenation reactivity, as changing the catalyst to 
more electron-withdrawing manganese porphyrins [such as 
Mn(TPFPP)Cl or Mn(TDCPP)Cl] or iron porphyrins sup-
presses the non-oxygenation reactivity and yields mainly 
Fig. 27  Aliphatic C–H 18F labeling mediated by manganese salen 
catalysts
Fig. 28  Manganese-catalyzed late-stage aliphatic C–H azidation
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oxygenation products. The stereoselectivity and the enan-
tioselectivity of the reactions can be controlled by the cata-
lyst through metal-mediated radical rebound. Such con-
trol of stereoselectivity is difficult to achieve with simple 
organic or inorganic radical trapping reagents.
The above examples show just a glimpse of the poten-
tial applications of radical rebound strategy in developing 
new radical organic transformations. Both the C–H acti-
vation and radical recombination approaches adopted by 
iron-containing oxygenases could likely be combined with 
current catalytic radical methodologies to afford new radi-
cal transformations. In one scenario, one can imagine that 
the carbon-centered radicals can be generated by the C–H 
activation via metal-oxo or similar metal-based hydrogen 
abstracting intermediates and subsequently be redirected 
to carbon–carbon or carbon-heteroatom bond formation via 
transition-metal mediated transformations. Such reactions 
would harness the controllable selectivity of metal-based 
hydrogen-abstracting intermediate in C–H activation step, 
which is hard to achieve with simple organic or inorganic 
radicals. In another case, carbon radicals could be gener-
ated with other radical initiation methods such as photore-
dox reactions, electrolysis, or other single-electron transfer 
(SET) processes, and later be captured by metal complexes 
[213–215]. The works of Kochi in 1970s have provided 
early examples of this type of reactions. He showed that 
various metal halide or pseudohalide complexes [i.e. 
CuBr2, Pb(OAc)4, etc.] were able to trap alkyl radicals 
generated by photolysis or thermolysis to afford halogena-
tion or pseudohalogenation products [210, 211, 216]. Very 
recently, this area of research has seen dramatic progress 
mainly due to the development of photoredox catalysis. 
New methodologies have been developed for the construc-
tion of various carbon–carbon and carbon-heteroatom 
bonds via trapping the intermediate carbon radicals with 
transition-metal complexes especially nickel and copper 
[214, 217–223].
Studies of Fe-containing oxygenases and related model 
compounds discussed above indicate that manganese and 
iron complexes also hold great premise for trapping the 
substrate radical intermediate, especially for the forma-
tion of carbon-halogen and carbon-pseudohalogen bonds. 
Following this design strategy, we recently developed the 
first decarboxylative fluorination reaction with fluoride ion 
(Fig. 30) [224]. In this reaction, the radical is generated 
via manganese-mediated oxidative decarboxylation. The 
generated radical is subsequently trapped by the MnIV–F 
intermediate to afford fluorination product. Another com-
pelling example was the aliphatic C–H azidation reac-
tion reported by Hartwig and co-workers in 2015 [225, 
226]. Mechanistic studies supported a reaction mechanism 
Fig. 29  Comparison of the enantioselectivity between Mn-catalyzed 
C–H azidation and fluorination
Fig. 30  Mn-catalyzed decarboxylative fluorination
Fig. 31  Fe-catalyzed aliphatic C–H azidation
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shown in Fig. 31. An initial one-electron oxidation between 
azidoiodinane 1 and iron(II) afforded a bezyloxyl radical 
and an azidoferric intermediate 2. Benzyloxyl will abstract 
a hydrogen from the substrate and the substrate radical will 
be subsequently trapped by azidoferric intermediate 2 to 
afford azidation product. The reaction can functionalize 
complex molecules with multiple aliphatic C–H bonds with 
high regio- and stereo-selectivity. For example, a gibberel-
lic acid derivative can be readily azidated giving a single 
diasterisomer with 75% yield. It is worth noting that in the 
absence of iron catalyst, azidoiodinane 1 can also azidate 
hydrocarbons with catalytic amount of radical initiators 
such as benzoyl peroxide with much lower stereoselectiv-
ity. This result highlighted the benefit of using metal com-
plexes as radical trapping agents.
In addition to non-oxygen atom rebound, other reaction 
pathways adopted by iron-containing oxygenases are also 
highly valuable to the organic synthesis, such as alkane 
desaturation and radical cyclizations. There are relatively 
few studies on these reactions. The elucidation of their bio-
chemical mechanisms and the design of synthetic model 
compounds to mimic the reactivities would definitely lead 
to new inventions in organic synthesis.
Concluding remarks
It has been 40 years since our initial work on the radical 
rebound mechanism. The goals all along were to compare, 
contrast, and unify biocatalytic mechanisms with biomi-
metic systems. Iron-containing oxygenases continue to 
comprise a highly active research area with numerous new 
enzymes and numerous new reaction discoveries being 
made every year. What is fascinating about these enzymes 
is the diverse range of transformations they can catalyze. 
What is even more intriguing is the common mechanistic 
foundation underlying these various reactions: activation of 
oxygen to form high-valent iron–oxygen containing inter-
mediates; abstraction of C–H bonds to yield radical inter-
mediate; and the participation of the carbon-centered radi-
cals in different reaction pathways giving rise to the diverse 
reactivities observed for iron-containing oxygenases. The 
study of the fundamental reactivities of these enzymes has 
inspired critical breakthroughs in synthetic organic chem-
istry, from early development of new molecular catalysts 
for alkane hydroxylations to the most recent progress in 
C–H halogenation reactions. We can expect iron-contain-
ing enzymes to continue powering the discoveries of new 
organic transformations because of the continuous dis-
coveries and understanding of new reactivities of these 
enzymes as well as the recent renaissance of radical chem-
istry in organic synthesis.
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